Fundz

Aurora Therapeutics

Boston, Massachusetts, United States · Biotechnology, Genetics, Health Care

Aurora Therapeutics is a biotechnology company focused on developing personalized gene editing therapies for patients with rare diseases. Founded by CRISPR pioneers Jennifer Doudna and Fyodor Urnov, the company aims to transform this technology into a scalable model that can treat many patients simultaneously. Aurora leverages modular gene editors and innovative regulatory strategies to address ra

Key facts

Headquarters
Boston, Massachusetts, United States
Employees
11
Industries
Biotechnology, Genetics, Health Care
Status
Private
Website
www.auroratherapeutics.com
LinkedIn
Company page

Recent activity at Aurora Therapeutics

Aurora Therapeutics funding history

DateRoundAmount
Jan 2026Seed$16.0M

Leadership

  • Thomas Wechsler, Chief Scientific Officer
  • Edward M. Kaye, Chief Executive Officer

Verified email and direct lines for Aurora Therapeutics’s decision-makers are on Fundz. See plans

Employee benefit plans

Aurora Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Aurora Therapeutics in the news

Companies similar to Aurora Therapeutics

About Aurora Therapeutics: questions and answers

What does Aurora Therapeutics do?

Aurora Therapeutics is a biotechnology company focused on developing personalized gene editing therapies for patients with rare diseases. Founded by CRISPR pioneers Jennifer Doudna and Fyodor Urnov, the company aims to transform this technology into a scalable model that can treat many patients simultaneously. Aurora leverages modular gene editors and innovative regulatory strategies to address ra

Where is Aurora Therapeutics headquartered?

Aurora Therapeutics is headquartered in Boston, Massachusetts, United States.

How many employees does Aurora Therapeutics have?

Aurora Therapeutics has about 11 employees.

Has Aurora Therapeutics raised funding?

Yes. Fundz has recorded 1 funding event for Aurora Therapeutics. The most recent, Seed of $16.0M, was in Jan 2026.

Who leads Aurora Therapeutics?

Edward M. Kaye is a Chief Executive Officer at Aurora Therapeutics.

What is the latest news on Aurora Therapeutics?

On Jan 09, 2026, Aurora Therapeutics secures $16 million seed funding from Menlo Ventures to develop personalized gene editing therapies for rare diseases.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Aurora Therapeutics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.